QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 139/8/1463    most recent jn.109.108761v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Nakamura, Y. Articles by Nakao, A. PubMed PubMed Citation Articles by Nakamura, Y. Articles by Nakao, A.

---

Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions

The Latent Form of Transforming Growth Factor-β Administered Orally Is Activated by Gastric Acid in Mice^1,2

³ Department of Immunology and ⁴ Department of Human Pathology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan; and ⁵ Atopy Research Center, Juntendo University School of Medicine, Tokyo 113-8421, Japan

Transforming growth factor-β (TGFβ) is abundant in mammalian milk in a latent form. However, whether the latent form of TGFβ in human milk is converted to the active form in vivo remains uncertain. To address this issue, we first investigated whether latent TGFβ or human milk-borne latent TGFβ was activated in an in vitro assay, simulating the effects of gastric acid. We then tested whether gastric acid was necessary for the activation of orally administered latent TGFβ or human milk-borne latent TGFβ in mice by inhibiting gastric acidity with cimetidine, an antagonist of H2-receptors. Latent TGFβ or human milk-borne latent TGFβ increased Smad-responsive promoter activity in MFB-F11 reporter cells at pH 1.2, but not at pH 7.0, regardless of the presence or absence of the gastric protease pepsin. In mice treated orally with latent TGFβ (5 µg/mouse), the phosphorylation of Smad2 and TGFβ target gene mRNA expression (TGFβ and Smad7) was increased in the small intestine (P < 0.05) and this effect was inhibited by cimetidine (100 mg/kg, intraperitoneally). Similarly, mice treated orally with 1200 µL/d of human milk containing latent TGFβ (3 µg/L) for 2 wk had increased TGFβ and Smad7 mRNA expression in the small intestine (P < 0.05) and this was inhibited by the antiacid treatment. Therefore, the latent form of TGFβ, such as TGFβ in human milk, can be activated by gastric acid following oral administration in mice. This process may be involved in the conversion of human milk-borne latent TGFβ to the active form in vivo.

^* To whom correspondence should be addressed. E-mail: anakao{at}yamanashi.ac.jp.

Manuscript received 13 April 2009. Initial review completed 11 May 2009. Revision accepted 22 May 2009.

Published online 10 June 2009.